dc.creatorSilveira, Marcelo Augusto Duarte
dc.creatorSouza, Sergio Pinto de
dc.creatorGalvão, Erica Batista dos Santos
dc.creatorTeixeira, Maurício Brito
dc.creatorGomes, Marcel Miranda Dantas
dc.creatorDamiani, Lucas Petri
dc.creatorBahiense, Bruno Andrade
dc.creatorCabral, Julia Barros
dc.creatorOliveira, Cicero Wandson Luiz Macedo de
dc.creatorMascarenhas, Talita Rocha
dc.creatorPinheiro, Priscila Carvalho Guedes
dc.creatorAlves, Milena Souza
dc.creatorMelo, Rodrigo Morel Vieira de
dc.creatorBerretta, Andresa Aparecida
dc.creatorLeite, Flávia Mendes
dc.creatorNonaka, Carolina Kymie Vasques
dc.creatorSouza, Bruno Solano de Freitas
dc.creatorMendes, Ana Verena Almeida
dc.creatorGuarda, Suzete Farias da
dc.creatorPassos, Rogério da Hora
dc.date.accessioned2022-05-10T11:57:21Z
dc.date.accessioned2023-09-05T15:39:01Z
dc.date.available2022-05-10T11:57:21Z
dc.date.available2023-09-05T15:39:01Z
dc.date.created2022-05-10T11:57:21Z
dc.date.issued2022
dc.identifierSILVEIRA, Marcelo Augusto Duarte et al. The use of standardized Brazilian green propolis extract (EPP-AF) as an adjunct treatment for hospitalized COVID-19 patients (BeeCovid2): a structured summary of a study protocol for a randomized controlled trial. Trials, n. 255, p. 1-7, 2022.
dc.identifier1745-6215
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/52597
dc.identifier10.1186/s13063-022-06176-1
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8668789
dc.languageeng
dc.publisherBMC
dc.rightsopen access
dc.titleThe use of standardized Brazilian green propolis extract (EPP-AF) as an adjunct treatment for hospitalized COVID-19 patients (BeeCovid2): a structured summary of a study protocol for a randomized controlled trial
dc.typeArticle


Este ítem pertenece a la siguiente institución